Improving your biomarker intelligence - Springer Nature and Amplion
In case you missed it, view our slides and recording to gain insight into how top organizations manage clinical information, particularly biomarker information.
What you will learn:
- Why are biomarkers important at different points of the healthcare value chain
- How do highly effective companies manage their clinical information to help cut trial times and increase likelihood of approval
- How can the AdisInsight and Amplion relationship move our customers up the biomarker intelligence maturity model
- How do the AdisInsight and Amplion products address high value use cases
Head of Product and Marketing at Amplion
As an enterprise software entrepreneur, Seth’s career has included co-founding a recruiting software company, and Workday, a huge success in the burgeoning SaaS enterprise software space. Seth is excited to see Amplion contribute to the realization of the promise of personalized medicine.
Seth writes actively on topics related to biomarkers and personalized medicine at our blog Biomarker Trends.
Content Development Manager, Adis Business Intelligence at Springer Nature
Inspired by innovation and providing value to customers, Kerryn has worked creating novel solutions for pharmaceutical companies for over 17 years. Working globally with clients in Europe, the US and Asia Pacific has provided Kerryn with insight into an array of pharmaceutical and healthcare environments and an understanding of the content and solutions available to meet different information needs.
To learn more about Amplion, Springer Nature and our new relationship: